All Type of News
Boryung eager to license out novel angiotensin II receptor antagonist
With its new angiotensin II receptor blocker, Fimasartan, Boryung Pharm is seeking partners that can progress further clinical trial and market in US or EU in the future.
Fimasartan is a novel, non-peptide angioten...
Japanese health authorities approves concurrent therapy of Fastic
Tokyo-headquartered pharmaceutical company, Astellas announced that an additional indication for nateglinide, has been recently approved in Japan, according to Ildong Pharm.
Nateglinide is a fast-acting postprandia...
Hanmi seeking to minimize erroneous dispensing at pharmacy
Hanmi Pharm has rolled its sleeves to prevent the possible erroneous dispensing at pharmacy.
The company said it plans to supply newly launched medicine, including Slimmer capsule, to pharmacies with four different...
Daewoong vice chairman named 'Entrepreneur of the Year'
Yoon Jae-seung, chairman of Daewoong Pharmaceutical Co., has named the Rising Star Entrepreneur of the Year in a business award for entrepreneurs in recognition of his efforts to transform a pharmaceutical company int...
Restructuring is key word for multinational firms
Restructuring is a key word for a number of foreign invested pharmaceutical firms, under the government's pressure to lower drug costs following the new drug pricing policy, so-called positive list system, and without...
Galvus gets nod for health insurance price
The health insurance price of Galvus (vildagliptin), a diabetes medicine produced by Novartis AG, has been finally agreed by Novartis Korea and the National Health Insurance Corporation.
The insurance price of Galv...
Pfizer Korea CEO named head of Pfizer business in Asia and Australia
Ahmet Goksun, President and CEO of Pfizer Korea, will be responsible for taking charge of overall business in Japan, Australia and New Zealand as of January 9, 2009.
The move comes after Pfizer Inc., the world's bi...
Green Cross aims for W615 billion sales
With its completion of new GMP plant in Osan, Chungchung Province last December, Green Gross Corporation has set an ambitious goal of 615 billion won in sales this year.
“We will produce a variety number of biodrug...
Roche Diagnostics Korea breaks 100 billion won in sales
Backed by successful introduction of innovative in-vitro diagnostics used in hospitals, such as CoaguChek XS system and cell analysis system, Roche Diagnostics Korea exceeded a 100 billion barrier this year and held i...
Deregulation to revitalize OTC market
OTC drugmakers is breathing a sigh of relief as the Korea Food and Drug Administration is actively moving ahead to deregulate validation rules governing OTC products with standardized dosage and formulation method.
...
